Morgan Stanley’s Roundhill GLP-1 & Weight Loss ETF OZEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.8K Sell
1,039
-500
-32% -$15.6K ﹤0.01% 6633
2026
Q1
$48K Buy
1,539
+500
+48% +$17K ﹤0.01% 6438
2025
Q4
$35.5K Hold
1,039
﹤0.01% 6535
2025
Q3
$28.4K Hold
1,039
﹤0.01% 6583
2025
Q2
$26.2K Hold
1,039
﹤0.01% 6568
2025
Q1
$24.6K Hold
1,039
﹤0.01% 6493
2024
Q4
$25.3K Hold
1,039
﹤0.01% 6500
2024
Q3
$28.7K Buy
1,039
+39
+4% +$1.08K ﹤0.01% 6388
2024
Q2
$26.6K Buy
+1,000
New +$25.8K ﹤0.01% 6369

Other funds holding OZEM

Morgan Stanley's OZEM Position: Q2 2026 in Review

Morgan Stanley reduced its Roundhill GLP-1 & Weight Loss ETF (OZEM) stake by 32% in Q2 2026, selling an estimated $15.6K and leaving 1,039 shares worth $33.8K. The position accounts for ﹤0.01% of the portfolio, ranked #6633.

Morgan Stanley first reported a position in OZEM in Q2 2024 and has held it in 9 quarters since. The position peaked at $48K in Q1 2026. 23 funds tracked by Wall St. Rank hold OZEM as of Q2 2026.

  • Morgan Stanley held 1,039 shares of Roundhill GLP-1 & Weight Loss ETF worth $33.8K as of Q2 2026.
  • Morgan Stanley sold 500 Roundhill GLP-1 & Weight Loss ETF shares in Q2 2026, an estimated $15.6K.
  • Roundhill GLP-1 & Weight Loss ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6633 holding.
  • Morgan Stanley first reported a position in Roundhill GLP-1 & Weight Loss ETF in Q2 2024 and has held it in 9 quarters since.
  • Morgan Stanley's Roundhill GLP-1 & Weight Loss ETF position peaked at $48K in Q1 2026.
  • 23 funds tracked by Wall St. Rank held Roundhill GLP-1 & Weight Loss ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.